Skip to main content
. 2020 May 24;12(11):10162–10179. doi: 10.18632/aging.103336

Figure 7.

Figure 7

Effects of the Mitoriboscin 23/G4 on tumor growth. The Mitoriboscin 23/G4 was tested at higher concentrations of 0.75, 1 and 2 mM. Note that 23/G4, at these concentrations, inhibited tumor growth (by 40% to 60%). Averages are shown + SEM. ***p<0.001.